Friday, 4 October 2013

Biogen's new MS drug maintains efficacy long term -study

Source Yahoo!
Oct 4 (Reuters) - Biogen Idec's hot-selling new multiple sclerosis drug Tecfidera remained effective for patients taking the medicine for at least four years with no new safety problems, according to interim data from a long-term study.  Read more here!